America Partners With Butler Schein Animal Health to Distribute
World’s Leading Animal Stem Cell Technology to U.S. Veterinarians
Global leader in animal stem cell technology is poised for significant
expansion through new partnership with top U.S. companion animal health
Las Vegas, Nevada (PRWEB) February 22, 2012
MediVet-America, the global leader in veterinary stem cell technology
and regenerative medicine, has entered into a distribution partnership
with Butler Schein Animal Health, a division of Henry Schein, the
leading companion animal health distribution company in the U.S., to
sell and distribute stem cell kits and equipment to veterinarians
serving the nation’s fast-growing $50 billion pet industry.
The announcement was made today at the Western Veterinary Conference in Las Vegas by Jeremy Delk, CEO of MediVet-America.
The two companies will partner to sell and distribute MediVet-America’s
advanced stem cell technology to more than 26,000 veterinary clinics
nationwide. Adult animal stem cell technology uses the body’s own
regenerative healing power to help treat dogs, cats, horses and other
animals suffering from painful arthritis, hip dysplasia and tendon,
ligament and cartilage injuries and other ailments.
The Adipose-Derived Stem Cell Procedure Kit and state of the art
equipment, co-developed with Medical Australia, enable veterinarians to
remove a small sample of fat, separate the stem cells, then activate an